David Townson

1st January, 1970

David Townson

Dr. Townson heads development programs for Immuno-oncology and Cell Therapy assets at Bayer.

Dr. Townson’s current development activities include: AhR-inhibition, DGK-inhibition, and allogeneic CAR-T treatment. In the past several years Dr. Townson’s successes include the global registration and launch of hematology and cell therapy assets as well as multiple INDs and early clinical testing of novel small-molecule and anti-body check-point therapies.


Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the

If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:

Paul Adams
+44 (0)20 7936 6948

Speaker opportunities

We identify and invite individuals we believe to be the best speakers in the market, if you think you can make a difference to the quality of our events please contact:

Chloe Roberts
E: Chloe.Roberts@arena-international.com
T: +44 (0)207 936 6822